Insider Trading activities of Pronai Therapeutics Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Pronai Therapeutics Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Pronai Therapeutics Inc since year 2005. Table 2 shows the detailed insider transactions of Pronai Therapeutics Inc since 2005. The reporting company's ticker symbol is SRRA. The reporting company's CIK number is 1290149.
The total value of stock buying since 2005 is $25,212,900.
The total value of stock sales since 2005 is $388,902.
The total value of stock option exercises since 2005 is $19,913.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Pronai Therapeutics Inc (SRRA).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-03 30,000 $42,900 0 $0 0 $0
2017-02 5,925,926 $8,000,000 0 $0 0 $0
2016-03 0 $0 3,000 $21,024 3,000 $2,907
2016-01 0 $0 33,973 $367,878 17,551 $17,006
2015-07 1,010,000 $17,170,000 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Pronai Therapeutics Inc insiders (SRRA)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-03-08 You Angie (Chief Bus. & Strat. Officer) Buy 30,000 1.43 42,900
2017-02-14 Topper James N (Director) Buy 5,925,926 1.35 8,000,000
2016-03-22 Chapman Wendy (SVP Clinical Operations) Sale 3,000 7.01 21,024
2016-03-22 Chapman Wendy (SVP Clinical Operations) Option Ex 3,000 .97 2,907
2016-01-22 Rodigueza Wendi (Chief Scientific Officer) Sale 1,000 9.66 9,660
2016-01-22 Chapman Wendy (SVP Clinical Operations) Sale 5,000 9.39 46,975
2016-01-22 Chapman Wendy (SVP Clinical Operations) Option Ex 5,000 .97 4,845
2016-01-21 Rodigueza Wendi (Chief Scientific Officer) Sale 1,000 10.32 10,323
2016-01-20 Rodigueza Wendi (Chief Scientific Officer) Sale 1,000 9.59 9,590
2016-01-15 Glover Nicholas (CEO and President) Sale 5,000 10.04 50,225
2016-01-15 Glover Nicholas (CEO and President) Option Ex 5,000 .97 4,845
2016-01-12 Lovejoy Chandra D (SVP of Reg. Affairs & Quality) Sale 20,973 11.50 241,105
2016-01-12 Lovejoy Chandra D (SVP of Reg. Affairs & Quality) Option Ex 7,551 .97 7,316
2015-07-21 Orbimed Private Investments V, Lp (Director) Buy 175,000 17.00 2,975,000
2015-07-21 Vivo Ventures Vii Affiliates Fund, L.p. (Other) Buy 220,000 17.00 3,740,000
2015-07-21 Cha Albert (Director) Buy 220,000 17.00 3,740,000
2015-07-21 Thompson Peter A. (Director) Buy 175,000 17.00 2,975,000
2015-07-21 Topper James N (Director) Buy 220,000 17.00 3,740,000

Insider trading activities including stock purchases, stock sales, and option exercises of SRRA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Pronai Therapeutics Inc (symbol SRRA, CIK number 1290149) see the Securities and Exchange Commission (SEC) website.